Actinium grants director 61.6K RSUs, 92.4K options
Director Ajit Shetty received new RSU and stock option awards from Actinium Pharmaceuticals, adding to his direct equity stake.
Rhea-AI Filing Summary
Actinium Pharmaceuticals, Inc. (symbol: ATNM) is the issuer of record for a Form 4 filing submitted to the SEC. Shetty Ajit reported acquisition or exercise transactions in this Form 4 filing.
Actinium Pharmaceuticals, Inc. (ATNM) reported that director Ajit Shetty received equity awards on September 2, 2026. He was granted 61,600 shares of Common Stock as restricted stock units, which vest in three equal annual installments, and 92,400 stock options exercisable at $1.00 per share that vest in fifty equal monthly tranches. Following these awards, he holds 62,357 shares of Common Stock directly and 92,400 stock options. No Rule 10b5-1 trading plan is reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F2 | 92,400 | $0.00 | $0.00 |
| Grant/Award | Common Stock F1 | 61,600 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents a grant of restricted stock units ("RSUs"). The RSUs vest as follows: 1/3 on the first anniversary of the date of grant, 1/3 on the second anniversary of the date of grant and 1/3 on the third anniversary of the date of grant.
- F2. The stock options vest and become exercisable in fifty equal monthly tranches beginning on the date of grant.
Key Figures
Key Terms
restricted stock units financial
vesting financial
stock options financial
exercise price financial
FAQ
What equity awards did director Ajit Shetty receive from ATNM on September 2, 2026?
How do the new RSUs granted to Ajit Shetty by ATNM vest?
What is the vesting schedule of Ajit Shetty’s new ATNM stock options?
Were Ajit Shetty’s ATNM transactions made under a Rule 10b5-1 trading plan?
AI-generated analysis. How Rhea-AI works. Not financial advice.